Suh H H, Tseng L F
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee 53226.
Pharmacol Biochem Behav. 1990 Apr;35(4):807-13. doi: 10.1016/0091-3057(90)90363-m.
Male ICR mice were rendered tolerant by intrathecal (IT) injection once a day with either mu-agonist, D-Ala2-NMePhe4-Gly-ol-enkephalin (DAMGO) or delta-agonist, D-Pen2-D-Pen5-enkephalin (DPDPE) (toleragen) by doubling the dose each day starting from 0.125 and 1 microgram for DAMGO and DPDPE, respectively, for 6 days. On day 6, the magnitude of tolerance was assessed by establishing IT dose-response lines for the effect of the chronic drug given as bolus injections (probe). The antinociception was assessed by the tail-flick and hot-plate test. Repeated IT injections of DPDPE reduced inhibition of the tail-flick and hot-plate response induced by DPDPE (ED50 values for DPDPE increase 10-fold) but not DAMGO. Repeated IT injections of DAMGO reduced inhibition of the tail-flick and hot-plate response induced by DAMGO (ED50 value for DAMGO increase 7- to 10-fold) but not DPDPE. The effects of the tolerance to mu- and delta-opioid receptor activity in the spinal cord on inhibition of the tail-flick and hot-plate response induced by intracerebroventricularly (ICV) administered beta-endorphin and morphine were then studied. beta-Endorphin or morphine at different doses were injected ICV 4 hr after the last IT injection of DPDPE or DAMGO. Repeated IT bolus injections of DPDPE reduced inhibition of the tail-flick response but not the hot-plate response induced by beta-endorphin. On the other hand, repeated IT bolus injections of DAMGO did not affect inhibition of the tail-flick and hot-plate response induced by beta-endorphin.(ABSTRACT TRUNCATED AT 250 WORDS)
雄性ICR小鼠通过鞘内(IT)注射产生耐受性,每天一次,分别使用μ-激动剂D-Ala2-NMePhe4-Gly-ol-脑啡肽(DAMGO)或δ-激动剂D-Pen2-D-Pen5-脑啡肽(DPDPE)(耐受原),从分别为0.125微克和1微克的DAMGO和DPDPE开始,每天剂量加倍,持续6天。在第6天,通过建立慢性药物推注注射(探针)效果的IT剂量反应线来评估耐受性的程度。通过甩尾和热板试验评估镇痛作用。重复IT注射DPDPE可降低DPDPE诱导的甩尾和热板反应的抑制作用(DPDPE的ED50值增加10倍),但对DAMGO无影响。重复IT注射DAMGO可降低DAMGO诱导的甩尾和热板反应的抑制作用(DAMGO的ED50值增加7至10倍),但对DPDPE无影响。然后研究了脊髓中对μ-和δ-阿片受体活性的耐受性对脑室内(ICV)注射β-内啡肽和吗啡诱导的甩尾和热板反应抑制的影响。在最后一次IT注射DPDPE或DAMGO后4小时,ICV注射不同剂量的β-内啡肽或吗啡。重复IT推注注射DPDPE可降低β-内啡肽诱导的甩尾反应的抑制作用,但对热板反应无影响。另一方面,重复IT推注注射DAMGO对β-内啡肽诱导的甩尾和热板反应的抑制作用无影响。(摘要截断于250字)